Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s traded shares stood at 54568.0 during the last session, with the company’s beta value hitting -0.94. At the close of trading, the stock’s price was $3.91, to imply a decrease of -0.51% or -$0.02 in intraday trading. The BDMD share’s 52-week high remains $13.52, putting it -245.78% down since that peak but still an impressive 73.15% since price per share fell to its 52-week low of $1.05. The company has a valuation of $139.70M, with an average of 0.46 million shares in intraday trading volume over the past 10 days and average of 117.75K shares over the past 3 months.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) trade information

After registering a -0.51% downside in the last session, Baird Medical Investment Holdings Limited (BDMD) has traded red over the past five days. The 5-day price performance for the stock is -11.54%, and -9.07% over 30 days. With these gigs, the year-to-date price performance is -64.19%. Short interest in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) saw shorts transact 75453.0 shares and set a 1.36 days time to cover.

BDMD Dividends

Baird Medical Investment Holdings Limited has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s Major holders

Baird Medical Investment Holdings Limited insiders hold 99.92% of total outstanding shares, with institutional holders owning 1.40% of the shares at 1668.36% float percentage. In total, 1.40% institutions holds shares in the company.

Going by data provided on Apr 30, 2025, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 15.93 shares. This is just over 0.04% of the total shares, with a market valuation of $62290.0